SEARCH

SEARCH BY CITATION

REFERENCES

  • Altman J, Bayer SA. 1995. Atlas of the prenatal rat brain development. Boca Raton: CRC Press, Inc.
  • Andrenacci D, Grimaldi MR, Panetta V, Riano E, Rugarli EI, Graziani F. 2006. Functional dissection of the Drosophila Kallmann's syndrome protein DmKal-1. BMC Genet 7: 47.
  • Ardouin O, Legouis R, Fasano L, David-Watine B, Korn H, Hardelin J, Petit C. 2000. Characterization of the two zebrafish orthologues of the KAL-1 gene underlying X chromosome-linked Kallmann syndrome. Mech Dev 90: 8994.
  • Ayari B, Soussi-Yanicostas N. 2007. FGFR1 and anosmin-1 underlying genetically distinct forms of Kallmann syndrome are co-expressed and interact in olfactory bulbs. Dev Genes Evol 217: 169175.
  • Bribián A, Barallobre MJ, Soussi-Yanicostas N, de Castro F. 2006. Anosmin-1 modulates the FGF-2-dependent migration of oligodendrocyte precursors in the developing optic nerve. Mol Cell Neurosci 33: 214.
  • Burchanowski BJ, Sternberger LA. 1980. Improved visualization of luteinizing hormone releasing hormone pathways by immunocytochemical staining of thick vibratome sections. J Histochem Cytochem 28: 361363.
  • Cariboni A, Pimpinelli F, Colamarino S, Zaninetti R, Piccolella M, Rumio C, Piva F, Rugarli EI, Maggi R. 2004. The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons. Hum Mol Genet 13: 27812791.
  • Dellovade TL, Hardelin JP, Soussi-Yanicostas N, Pfaff DW, Schwanzel-Fukuda M, Petit C. 2003. Anosmin-1 immunoreactivity during embryogenesis in a primitive eutherian mammal. Brain Res Dev Brain Res 140: 157167.
  • Duke VM, Winyard PJ, Thorogood P, Soothill P, Bouloux PM, Woolf AS. 1995. KAL, a gene mutated in Kallmann's syndrome, is expressed in the first trimester of human development. Mol Cell Endocrinol 110: 7379.
  • Farmer SF, Harrison LM, Mayston MJ, Parekh A, James LM, Stephens JA. 2004. Abnormal cortex-muscle interactions in subjects with X-linked Kallmann's syndrome and mirror movements. Brain 127: 385397.
  • Franco B, Guioli S, Pragliola A, Incerti B, Bardoni B, Tonlorenzi R, Carrozzo R, Maestrini E, Pieretti M, Taillon-Miller P, et al. 1991. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 353: 529536.
  • Freund TF, Buzsaki G. 1996. Interneurons of the hippocampus. Hippocampus 6: 347470.
  • González-Martínez D, Kim SH, Hu Y, Guimond S, Schofield J, Winyard P, Vannelli GB, Turnbull J, Bouloux PM. 2004. Anosmin-1 modulates fibroblast growth factor receptor 1 signaling in human gonadotropin-releasing hormone olfactory neuroblasts through a heparan sulfate-dependent mechanism. J Neurosci 24: 1038410392.
  • Hardelin JP, Levilliers J, del Castillo I, Cohen-Salmon M, Legouis R, Blanchard S, Compain S, Bouloux P, Kirk J, Moraine C, et al. 1992. X chromosome-linked Kallmann syndrome: stop mutations validate the candidate gene. Proc Natl Acad Sci U S A 89: 81908194.
  • Hardelin JP, Levilliers J, Blanchard S, Carel JC, Leutenegger M, Pinard-Bertelletto JP, Bouloux P, Petit C. 1993. Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome. Hum Mol Genet 2: 373377.
  • Hardelin JP, Julliard AK, Moniot B, Soussi-Yanicostas N, Verney C, Schwanzel-Fukuda M, Ayer-Le Lievre C, Petit C. 1999. Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: implications for the developmental anomalies of X chromosome-linked Kallmann syndrome. Dev Dyn 215: 2644.
  • Hudson ML, Kinnunen T, Cinar HN, Chisholm AD. 2006. C. elegans Kallmann syndrome protein KAL-1 interacts with syndecan and glypican to regulate neuronal cell migrations. Dev Biol 294: 352365.
  • Itoh M, Houdou S, Mizushima M, Tokita Y, Kawahara H, Ishii S, Ohama E. 1997. Two autopsied cases of Kallmann's syndrome with dysplasia of the hippocampus. J Child Neurol 12: 510513.
  • Krams M, Quinton R, Mayston MJ, Harrison LM, Dolan RJ, Bouloux PM, Stephens JA, Frackowiak RS, Passingham RE. 1997. Mirror movements in X-linked Kallmann's syndrome. II. A PET study. Brain 120(pt 7): 12171228.
  • Legouis R, Cohen-Salmon M, del Castillo I, Levilliers J, Capy L, Mornow JP, Petit C. 1993. Characterization of the chicken and quail homologues of the human gene responsible for the X-linked Kallmann syndrome. Genomics 17: 516518.
  • Leigh RJ, Zee DS. 1999. The neurology of eye movements. 3rd ed. Philadelphia: FA Davis Co.
  • MacColl G, Bouloux P, Quinton R. 2002. Kallmann syndrome: adhesion, afferents, and anosmia. Neuron 34: 675678.
  • Mayston MJ, Harrison LM, Quinton R, Stephens JA, Krams M, Bouloux PM. 1997. Mirror movements in X-linked Kallmann's syndrome. I. A neurophysiological study. Brain 120(pt 7): 11991216.
  • Navarro-López Jde D, Alvarado JC, Márquez-Ruiz J, Escudero M, Delgado-García JM, Yajeya J. 2004. A cholinergic synaptically triggered event participates in the generation of persistent activity necessary for eye fixation. J Neurosci 24: 51095118.
  • Paxinos G. 2004. The rat nervous system. Elsevier Academic Press.
  • Paxinos G, Watson W. 2007. The rat brain in stereotaxic coordinates. London: Academic Press.
  • Rogers MC, Silverman AJ, Gibson MJ. 1997. Gonadotropin-releasing hormone axons target the median eminence: in vitro evidence for diffusible chemoattractive signals from the mediobasal hypothalamus. Endocrinology 138: 39563966.
  • Rugarli EI, Lutz B, Kuratani SC, Wawersik S, Borsani G, Ballabio A, Eichele G. 1993. Expression pattern of the Kallmann syndrome gene in the olfactory system suggests a role in neuronal targeting. Nat Genet 4: 1926.
  • Schwankhaus JD, Currie J, Jaffe MJ, Rose SR, Sherins RJ. 1989. Neurologic findings in men with isolated hypogonadotropic hypogonadism. Neurology 39: 223226.
  • Schwanzel-Fukuda M, Bick D, Pfaff DW. 1989. Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res Mol Brain Res 6: 311326.
  • Seo SW, Shin HY, Kim SH, Han SW, Lee KY, Kim SM, Heo JH. 2004. Vestibular imbalance associated with a lesion in the nucleus prepositus hypoglossi area. Arch Neurol 61: 14401443.
  • Soussi-Yanicostas N, Hardelin JP, Arroyo-Jiménez MM, Ardouin O, Legouis R, Levilliers J, Traincard F, Betton JM, Cabanie L, Petit C. 1996. Initial characterization of anosmin-1, a putative extracellular matrix protein synthesized by definite neuronal cell populations in the central nervous system. J Cell Sci 109(pt 7): 17491757.
  • Soussi-Yanicostas N, de Castro F, Julliard AK, Perfettini I, Chédotal A, Petit C. 2002. Anosmin-1, defective in the X-linked form of Kallmann syndrome, promotes axonal branch formation from olfactory bulb output neurons. Cell 109: 217228.
  • Spassky N, Goujet-Zalc C, Parmantier E, Olivier C, Martínez S, Ivanova A, Ikenaka K, Macklin W, Cerruti I, Zalc B, Thomas JL. 1998. Multiple restricted origin of oligodendrocytes. J Neurosci 18: 83318343.
  • Spassky N, de Castro F, Le Bras B, Heydon K, Quéraud-LeSaux F, Bloch-Gallego E, Chédotal A, Zalc B, Thomas JL. 2002. Directional guidance of oligodendroglial migration by class 3 semaphorins and netrin-1. J Neurosci 22: 59926004.
  • Takiyama Y. 2007. Sacsinopathies: sacsin-related ataxia. Cerebellum 28: 17.
  • White BJ, Rogol AD, Brown KS, Lieblich JM, Rosen SW. 1983. The syndrome of anosmia with hypogonadotropic hypogonadism: a genetic study of 18 new families and a review. Am J Med Genet 15: 417435.
  • Yousem DM, Turner WJ, Li C, Snyder PJ, Doty RL. 1993. Kallmann syndrome: MR evaluation of olfactory system. AJNR Am J Neuroradiol 14: 839843.
  • Yousem DM, Geckle RJ, Bilker W, McKeown DA, Doty RL. 1996. MR evaluation of patients with congenital hyposmia or anosmia. AJR Am J Roentgenol 166: 439443.